Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03055988
What this trial is testing

Cardiovascular Function in COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 76
Early research (Phase 1)Study completedNCT01189201
What this trial is testing

Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food

Who this might be right for
Healthy
Boehringer Ingelheim 42
Early research (Phase 1)Study completedNCT02815644
What this trial is testing

Empa/Lina FDC Food Effect Study (Japan)

Who this might be right for
Healthy
Boehringer Ingelheim 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05625399
What this trial is testing

Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 579
Early research (Phase 1)Study completedNCT01747083
What this trial is testing

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

Who this might be right for
Type 2 Diabetes
LG Life Sciences 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05352672
What this trial is testing

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,546
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Early research (Phase 1)Study completedNCT01975961
What this trial is testing

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

Who this might be right for
Dyslipidemia & Hypertension
Yuhan Corporation 185
Post-approval studies (Phase 4)Study completedNCT04442737
What this trial is testing

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787613
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

Who this might be right for
NSCLC Stage IV
Shanghai Henlius Biotech 132
Early research (Phase 1)Study completedNCT05090449
What this trial is testing

Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 36
Early research (Phase 1)Study completedNCT00351949
What this trial is testing

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Who this might be right for
Stage IV Renal Cell Carcinoma
Immutep S.A.S. 24
Testing effectiveness (Phase 2)Study completedNCT04326257
What this trial is testing

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dan Zandberg 20
Testing effectiveness (Phase 2)Looking for participantsNCT06642792
What this trial is testing

AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin Lymphoma
Akeso 280
Early research (Phase 1)Study completedNCT05101109
What this trial is testing

Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
ABL Bio, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT04150965
What this trial is testing

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Who this might be right for
Multiple MyelomaRelapsed Refractory Multiple Myeloma
Multiple Myeloma Research Consortium 14
Early research (Phase 1)Study completedNCT04065581
What this trial is testing

Bioequivalence Study for Acarbose/Metformin FDC

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 24
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Early research (Phase 1)Study completedNCT01463774
What this trial is testing

Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 74
Large-scale testing (Phase 3)Study completedNCT07354516
What this trial is testing

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
Qlaris Bio, Inc. 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation